Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	27.26	45.68	43.46	79.67	53.65	3.2
Short-Term Investments	326.05	115.04	71.19	-	0.09	0.03
Cash & Short-Term Investments	353.31	160.72	114.65	79.67	53.74	3.23
Cash Growth	120.90%	40.18%	43.90%	48.26%	1564.29%	-
Other Receivables	2	-	-	-	0.05	-
Receivables	2	-	-	-	0.05	-
Prepaid Expenses	7.7	8.09	10.33	2.38	0.03	0.33
Restricted Cash	-	-	-	-	0.05	-
Other Current Assets	1.13	3.22	0.72	0.48	0.39	0
Total Current Assets	364.13	172.02	125.7	82.54	54.26	3.57
Property, Plant & Equipment	4.29	3.04	5.22	-	-	1.39
Long-Term Investments	-	0.01	0.06	0.87	-	-
Other Long-Term Assets	0.14	0.47	0.46	0.34	0.29	0.42
Total Assets	368.56	175.55	131.44	83.75	54.55	5.38
Accounts Payable	4.6	11.12	11.99	1.39	0.91	0.34
Accrued Expenses	19.7	8.75	10.96	5.93	0.54	0.38
Current Portion of Leases	1.87	2.44	2.65	-	-	0.12
Other Current Liabilities	0.29	-	-	0.38	0.96	0.22
Total Current Liabilities	26.46	22.3	25.6	7.69	2.41	1.06
Long-Term Debt	50.47	49.88	24.81	4.92	-	-
Long-Term Leases	2.57	1.4	3.83	-	-	0.01
Other Long-Term Liabilities	-	0.29	0.29	1.54	1.92	0.76
Total Liabilities	79.5	73.86	54.53	14.16	4.33	1.83
Common Stock	0.06	0.04	0.03	0.02	-	-
Additional Paid-In Capital	705.78	410.49	290.22	193.63	2.1	1.49
Retained Earnings	-417.83	-309.1	-213.11	-124.06	-91.45	-38.03
Comprehensive Income & Other	1.04	0.25	-0.22	-	-	-
Total Common Equity	289.06	101.69	76.91	69.59	-89.35	-36.55
Shareholders' Equity	289.06	101.69	76.91	69.59	50.23	3.55
Total Liabilities & Equity	368.56	175.55	131.44	83.75	54.55	5.38
Total Debt	54.91	53.71	31.29	4.92	-	0.13
Net Cash (Debt)	298.4	107.01	83.37	74.75	53.74	3.1
Net Cash Growth	128.80%	28.36%	11.53%	39.10%	1635.23%	-
Net Cash Per Share	5.82	2.51	3.14	5.56	167.96	10.49
Filing Date Shares Outstanding	63.32	54.45	44.26	27.05	0.36	0.3
Total Common Shares Outstanding	55.03	44.45	27.8	21.28	0.36	0.3
Working Capital	337.67	149.72	100.1	74.85	51.86	2.51
Book Value Per Share	5.25	2.29	2.77	3.27	-251.47	-123.75
Tangible Book Value	289.06	101.69	76.91	69.59	-89.35	-36.55
Tangible Book Value Per Share	5.25	2.29	2.77	3.27	-251.47	-123.75
Machinery	-	-	-	-	-	1.06
Leasehold Improvements	-	-	-	-	-	0.42

Source: S&P Capital IQ. Standard template. Financial Sources.